Pilot study completes

Last edited: June 30, 2017

Pretest Questionnaire – Study 2
This annotated questionnaire is color coded:
 BLACK= Question stems, response options and instructions that are to appear on screen.
 BLUE = Programming notes, skip patterns and logical operators.
 RED= Value names and labels, which are NOT to appear on screen. These correspond to
parameters set in the data shell.
 GREY= Variable names (i.e., question numbers), which will NOT to appear on screen. These
correspond to variable names in the datashell.
[QUOTA REQUIREMENT: Highest education level 20% of the CONSUMER sample for must be
high school graduate or less]
[Screener Intro Screen will be presented here]
[PROGRAMMER: IF COHORT = 2 ‘PCP’, SKIP S1_C THROUGH S4_C; GO TO S1_P]
[----------------------------------------New Screen----------------------------------------]
[Screener - Consumers, English-speaking adults in the United States]
[DISPLAY S1_C IF COHORT = 1 ‘Consumer’]
[NUMERICAL FIELDS]
S1_C. What is your age, height and weight?
S1_C_age.
Age: ___ years
[Consumers be at least 18 to remain Eligible]
S1_C_ft. \ S1_C_in.
Height: ____feet ____inches (your best guess is okay)
S1_C_lbs.
Weight _____pounds (your best guess is okay)
[PROGRAMMER: IF COHORT = 1 ‘Consumer’ AND S1_C _age < 18,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S8; GO TO S2_C]
[PROGRAMMER: RN to calculate derived variable
2
BMI = [S1_C_lbs / (S1_C _ft*12+S1_C _in) ] × 703]
[PROGRAMMER: IF COHORT = 1 ‘Consumer’ AND BMI < 30,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S8; GO TO S2_C]
[SINGLE PUNCH]
S2_C. What is your current occupation?
1 Healthcare provider (e.g., physician, nurse, counselor, physical therapist)
2 Pharmaceutical employee (e.g., pharma rep)
3 Market research employee/advertising employee
4 Employee of the Department of Health and Human Services
5 All other occupations
[Consumers must select 5 to remain Eligible]
[PROGRAMMER: IF COHORT = 1 ‘Consumer’ AND S2_C !== 5 ‘All other occupations’,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S8; GO TO S3_C]
[SINGLE PUNCH]

1

Last edited: June 30, 2017

S3_C. What is the highest level of school you have completed or the highest degree you have received?
1
Less than high school
2
High school graduate—high school diploma or the equivalent (for example: GED)
3
Some college but no degree
4
Associate degree in college
5
Bachelor’s degree (for example: BA, AB, BS)
6
Advanced or postgraduate degree (for example: Master’s degree, MD, DDS, JD, PhD,
EdD)
[QUOTA REQUIREMENT: IF COHORT = 1 ‘Consumer’, RESPONDENTS WHO SELECT S3_C
= 1 ‘Less than HS’ OR S3_C = 2 ‘HS grad’ MUST COMPRISE 20% OF COMPLETES]
[SINGLE PUNCH]
S4_C. What is your annual household income?
1 Less than $30,000 per year
2 $30,001 to $75,000 per year
3 $75,001 to $150,000 per year
4 More than $150,000 per year
997 Prefer not to answer
[PROGRAMMER: IF COHORT = 1 ‘Consumer’, SKIP S1_P THROUGH S5_P; GO TO S6]
[----------------------------------------New Screen----------------------------------------]
[Screener Items English-speaking PCPs, in the United States]
[DISPLAY S1_P IF AND COHORT = 2 ‘PCP’]
[SINGLE PUNCH]
S1_P. Which of the following best describes your profession?
1 Medical doctor/physician
 [PCPs must select 1 to remain Eligible]
2 Physician assistant
3 Nurse practitioner
4 Other
[PROGRAMMER: IF COHORT = 2 ‘PCP’ AND S1_P !== 1 ‘Medical doctor/physician’,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S8; SKIP S2_P, GO TO S3_P]

[DISPLAY S2_P IF S1_P = 1 ‘Medical doctor/physician’]
[SINGLE PUNCH]
S2_P. Do you consider yourself a primary care provider or specialist?
1 Primary care provider
 [PCPs must select 1 to remain Eligible]
2 Specialist
[PROGRAMMER: IF COHORT = 2 ‘PCP’ AND S2_P !== 1 ‘Primary care provider’,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S8; GO TO S3_P]
[SINGLE PUNCH]

2

Last edited: June 30, 2017

S3_P. Which of the following best describes your practice?
1 Family practice
 [PCPs must say 1 ‘Family practice’, OR
2 General practice
 2 ‘General practice, OR
3 Internal medicine
 3 ‘Internal medicine’ to remain Eligible]
4 Other
[PROGRAMMER: IF COHORT = 2 ‘PCP’ AND (S3_P = 4 ‘Other’ OR S3_P = ),
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S8; GO TO S4_P]
[NUMERICAL FIELD; SET RANGE 0 – 100]
S4_P. In a typical week, what percentage of your time is spent on direct patient care, such as seeing
patients and reviewing their medical records? If you are not sure, please provide your best guess.
_____%
 [PCPs must say at least 50% to remain Eligible]
[PROGRAMMER: IF COHORT = 2 ‘PCP’ AND S4_P < 50,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S8; GO TO S5_P]
[MULTIPLE PUNCH]
[PROGRAMMER: Multipunch response items should be saved to dataset as binary variables with
response options: 1=’Selected’ OR 0=’Not selected’.]
S5_P. Do you treat patients with any of the following conditions? Select all that apply.
S5_P_1.
Asthma
S5_P_2.
Obesity
 [PCPs must check obesity to remain Eligible]
S5_P_3.
Chronic pain
S5_P_4.
High cholesterol
S5_P_5.
Diabetes
S5_P_6.
Allergies
[PROGRAMMER: IF COHORT = 2 ‘PCP’ AND S5_P_2 !== 1 ‘Selected’,
SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE after S8; GO TO S6]
[----------------------------------------New screen----------------------------------------]
[SINGLE PUNCH]
S6. What is your gender?
1
Male
2
Female
[SINGLE PUNCH]
S7. Are you:
1
Hispanic or Latino
2
Not Hispanic or Latino
3
Prefer not to answer
[MULTIPLE PUNCH]
[PROGRAMMER: Multi-punch response items should be saved to dataset as binary variables
with response options: 1=’Selected’ OR 0=’Not selected’.]

3

Last edited: June 30, 2017

S8. What is your race? Select all that apply.
S8_1. American Indian or Alaska Native
S8_2. Asian
S8_3. Black or African American
S8_4. Native Hawaiian or other Pacific Islander
S8_5. White
S8_6. Other
S8_7. Prefer not to answer
[If selected, no other options can be selected]
PROGRAMMER: IF Q8_7 = 1 ‘Selected’, DISABLE OPTIONS S8_1 – S8_6]
[----------------------------------------New screen----------------------------------------]
[DISPLAY ‘Thank and Terminate’ IF EFLAG=0 ‘INELIGIBLE]
[Thank and Terminate]
We’re sorry, but you are not eligible for this study. There are many possible reasons why people are not
eligible for this study. These reasons were decided earlier by the researchers. However, thank you for
your interest in this study and for taking the time to answer our questions today.
[IF EFLAG=0 ‘INELIGIBLE, END HERE]
[----------------------------------------New screen----------------------------------------]
[DISPLAY]
Thank you for your interest in this research study. The purpose of the study is to learn more about
prescription drug websites.
You are one of about {IF PRETEST: “600”, IF MAIN STUDY: “1,500“} people in the United States who
are being asked to take a survey about a new prescription drug.
If you agree to participate, you will look at a website for a new prescription drug and then answer some
survey questions about what you saw. Viewing the website and completing the survey will take
approximately 20 minutes.
[----------------------------------------New screen----------------------------------------]
[DISPLAY]
This survey is being conducted by RTI International (RTI), an independent nonprofit research
organization, on behalf of a public health agency. RTI is working with Research Now to conduct this
survey but is not affiliated with Research Now in any way.
Possible Risks or Discomforts
There are no known risks to participating in this study. Although the survey questions we ask are not
meant to be sensitive, there is always a chance that you may feel uncomfortable with some of the
questions. You do not have to answer any question that you don’t want to answer. There is also a
potential risk of loss of confidentiality. Every effort will be made to protect your information, but this cannot
be guaranteed.
Benefits

4

Last edited: June 30, 2017

There are no individual benefits for participants. However, your responses are very important because
they will help researchers understand how people make decisions about medications.
Confidentiality
As with other surveys you receive from Research Now, the privacy and confidentiality of your information
is of the highest importance, and we are committed to maintaining a secure environment in which you can
participate. All information collected in this survey will be kept confidential to the extent provided by law.
Your name and your email address will not be shared outside of Research Now, and they will not be
associated with your answers or used in any report. The information obtained from all of the surveys will
be combined into a summary report so that details of individual questionnaires cannot be linked to a
specific participant. You will not be recontacted about this research study in the future.
Reimbursement
In appreciation for your time, you will receive {$5.00 in e-Rewards Currency / an honorarium of $27.00}
for completing the survey.
Right to Refuse or Withdraw
Your participation in this study is completely voluntary, and you can withdraw from the study for any
reason at any time without penalty.
Persons to Contact
If you have questions about this survey, please contact Member Services at http://www.erewards.com/contactus.do, and someone will direct your questions to the appropriate researchers at RTI.
If you have questions about your rights as a participant, you can call RTI’s Office of Research Protection
toll-free at 1-866-214-2043.

[----------------------------------------New screen----------------------------------------]
[SINGLE PUNCH]
Consent. If you have read the previous screens and agree to participate, please click the Yes button. If
not, click the No button.
1

Yes, I agree to participate.

[Go to ‘Randomization’]

2

No, I do not agree to participate.

[End survey]

[PROGRAMMER: IF CONSENT = 1 ‘Yes’, GO TO ‘Randomization’]
[PROGRAMMER: IF CONSENT !== 1 ‘Yes’, SET EFLAG=0 ‘INELIGIBLE’ – TERMINATE]
[PROGRAMMER: Randomly assign participants to one of three experimental conditions.
Record assignment in variable XCONDITION with possible values 1 ‘Control’, 2 ‘Implicit’,
OR 3 ‘ Explicit.
USE PURE RANDOM ASSIGNMENT TO ASSIGN PARTICIPANTS TO EXPERIMENTAL
CONDITION. DO NOT USE LEAST-FILLS. DO NOT CAP.]
[----------------------------------------New screen----------------------------------------]
[Intro screen 1]

5

Last edited: June 30, 2017

[DISPLAY ‘Intro screen 1’ IF EFLAG=1 ‘ELIGIBLE’]
Before continuing, here are some helpful tips for taking the survey:
 You may skip any question you do not want to answer. If you do skip a question, red text will
appear to let you know that the question was skipped. If that question was accidentally left blank,
then you can provide an answer before moving to the next page.
 Once you have moved to the next page in the survey, you will not be able to return to the
previous page.
 Keep in mind that you may need to scroll to see all the items on a page.
 Make sure you are comfortable and can read the screen from where you sit.
[----------------------------------------New screen----------------------------------------]
[DISPLAY]
You are among a small group of people selected to take part in this study and your responses are
very important.
On the next screen, we will ask you to look at a picture of a website that is under
development for a new prescription drug.
The researchers are looking at how {people / providers} think about drug information. It is part of
an effort to make drug websites more helpful. We are not connected with the drug being
promoted, so please give us your honest reaction to the website.
Carefully read the website to see what you think and feel about it. After you finishing viewing it,
we will ask you some questions about what you saw.
[----------------------------------------New screen----------------------------------------]
[PROGRAMMER: Display website correspondent to the participant’s experimental
condition:
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 1 ‘Control’, DISPLAY IMAGE:
CID_S2_Cons_1.pdf
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 2 ‘Implicit’, DISPLAY IMAGE:
CID_S2_Cons_2.pdf
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 3 ‘Explicit’, DISPLAY IMAGE:
CID_S2_Cons_3.pdf
IF COHORT = 2 ‘PCP’ AND XCONDITION = 1 ‘Control’, DISPLAY IMAGE:
CID_S2_PCP_1.pdf
IF COHORT = 2 ‘PCP’ AND XCONDITION = 2 ‘Implicit’, DISPLAY IMAGE:
CID_S2_PCP_2.pdf
IF COHORT = 2 ‘PCP’ AND XCONDITION = 3 ‘Explicit’, DISPLAY IMAGE:
CID_S2_PCP_3.pdf ]
Please click the ‘Next’ button to continue. Once you leave this screen you will not be able to return to it.
[Disable the “Next” button for 5 seconds]

6

Last edited: June 30, 2017

[----------------------------------------New screen----------------------------------------]
[GRID: SINGLE PUNCH]
These statements may or may not have been in the [DRUG] website.
Please mark whether you saw, did not see, or don’t know for each of the statements:

[PROGRAMMER: RANDOMIZE ORDER OF ITEMS Q1_a – Q1_g]
Q1_a. {You / Your patients} can lose weight by taking [DRUG] along with
any diet.
Q1_b. Taking [DRUG] once a day is the only thing {you / your patients}
need to do to get more results.
Q1_c. [DRUG] must be used with a well-balanced, reduced-calorie diet to
increase weight loss.
Q1_e. In a clinical trial, people who took [DRUG] lost five times more
body weight than people who {only received nutritional counseling
/ took a placebo}.
Q1_f. [DRUG] works better than other prescription drugs to help people
lose weight.
Q1_g. [DRUG] is the number one prescribed weight loss drug.

Yes – I
saw
this in
the
website

No – I
did not
see
this in
the
website

1

2

[----------------------------------------New screen----------------------------------------]
[INSERT THIS TEXT ABOVE THE IMAGE]
Here is a portion of the website that you saw. The text has been blurred.
[PROGRAMMER: IF COHORT = 1 ‘Consumer’, DISPLAY IMAGE: CID_S2_Cons_blur.jpg]

[PROGRAMMER: IF COHORT = 2 ‘PCP’, DISPLAY IMAGE: CID_S2_PCP_blur.jpg]

7

Last edited: June 30, 2017

[SINGLE PUNCH]
Q2. When you looked at the website the first time, how closely did you read the information in the blue
box?
1 I did not read it.
[Continue to Q3]
2 I skimmed it.
[GO TO Q4]
3 I read it carefully. [GO TO Q4]
[PROGRAMMER: IF Q2 !== 1 ‘I did not read it’, SKIP Q3, GO TO Q5]
[----------------------------------------New screen----------------------------------------]
[SINGLE PUNCH]
Q3. Please indicate why you did not read the information in the blue box when you looked at the website
the first time.
1 I did not notice it.
2 I did not think it was important.
3 I did not want to take the time to read it.
4 Other
[TEXTBOX] Q3_Open.__________________
[PROGRAMMER: IF Q3 = 3 ‘Other’, ENABLE TEXTBOX FOR Q3_Open]
[----------------------------------------New screen----------------------------------------]
[DISPLAY]
To what extent do you believe these statements are true or false?
Click and drag the square to a point on the scale that best reflects your opinion.
[SLIDERS; RANDOMIZE ORDER OF ITEMS Q5 – Q9]
Q5. {You / Your patients} can lose weight by taking [DRUG] along with any diet.
Definitely false
1
2
3
4
5
6

Definitely true

Q6.
Taking [DRUG] once a day is the only thing {you / your patients} need to do to get more results.
Definitely false
Definitely true

8

Last edited: June 30, 2017

1

2

3

4

5

6

Q7. [DRUG] must be used with a well-balanced, reduced-calorie diet to increase weight loss.
Definitely false
Definitely true
1
2
3
4
5
6
Q9.

In a clinical trial, people who took [DRUG] lost five times more body weight than people who {only
received nutritional counseling / took a placebo}.
Definitely false
Definitely true
1
2
3
4
5
6
[PROGRAMMER: IF COHORT = 2 ‘PCP’, SKIP Q10_C, GO TO Q11_P]

[----------------------------------------New screen----------------------------------------]
[ASK Q10_C IF COHORT = 1 ‘Consumer’]
[SINGLE PUNCH]
Q10_C. Are you currently taking, or have you ever taken, any prescription drug(s) for weight loss?
1 Currently taking
2 Have taken in the past but not currently taking
3 Have never taken
[PROGRAMMER: IF Q10_C !== 1 ‘Currently taking’, SKIP Q11_P GO TO Q11_C_1]
[PROGRAMMER: IF Q10_C = 1 ‘Currently taking’, SKIP Q11_P AND Q11_C_1 GO TO
Q11_C_2]
[----------------------------------------New screen----------------------------------------]
[SLIDERS]
[DISPLAY]
Click and drag the square to a point on the scale that best reflects how much you agree or disagree with
each statement.
[ASK Q11_P IF COHORT = 2 ‘PCP’]
Q11_P. If I had an obese patient, I would consider prescribing [DRUG].
Strongly disagree
1
2
3
4
5

Strongly agree
6

[PROGRAMMER: IF COHORT = 2 ‘PCP’, SKIP Q11_C_1 AND Q11_C2, GO TO Q12]
[ASK Q11_C_1 IF COHORT = 1 ‘Consumer’ AND Q10_C !== 1 ‘Currently taking’]
Q11_C_1.
If I were to take a prescription weight loss drug, I would consider taking [DRUG].
Strongly disagree
Strongly agree
1
2
3
4
5
6
[PROGRAMMER: SKIP Q11_C_2 GO TO Q12]

9

Last edited: June 30, 2017

[ASK Q11_C_1 IF COHORT = 1 ‘Consumer’ AND Q10_C = 1 ‘Currently taking’]
Q11_C_2.
I would consider switching my current prescription weight loss drug to [DRUG].
Strongly disagree
Strongly agree
1
2
3
4
5
6
[PROGRAMMER: GO TO Q12]
[----------------------------------------New screen----------------------------------------]
[SLIDERS]
Click and drag the square to a point on the scale that best reflects how much you agree or disagree with
each statement.
Q12. [DRUG] is safer than other prescription weight loss drugs.
Strongly disagree
1
2
3
4
5

6

Q13. [DRUG] is more effective than other prescription weight loss drugs.
Strongly disagree
1
2
3
4
5

6

Q14. The website exaggerates the benefits of [DRUG].
Strongly disagree
1
2
3
4

6

Strongly agree

Strongly agree

Strongly agree
5

[----------------------------------------New screen----------------------------------------]
[SLIDERS; RANDOMIZE ITEM ORDER Q15 – Q18]
[DISPLAY]
Click and drag the square to a point on the scale that best reflects your opinion of the website.
I felt the website was…
Q15.
Confusing

Clear
1

Q16.

4

5

2

3

4

5

6

Not believable

Believable
2

3

4

5

6

Misleading

Honest
1

2

3

4

5

[----------------------------------------New screen----------------------------------------]

Q19.

6
Good

1
Q18.

3

Bad
1

Q17.

2

[SLIDER]
How carefully did you read the [DRUG] website?

10

6

Last edited: June 30, 2017

I skimmed the
website

I read the
website carefully

1
2
3
4
5
[----------------------------------------New screen----------------------------------------]

6

[SLIDERS]
[DISPLAY]
Click and drag the square to a point on the scale that best reflects your opinion.
Q20. How likely are you to look for more information about [DRUG]?
Not at all likely
1
2
3
4
5

Extremely likely
6

Q21. If one of your {family members or close friends / patients} were considering using a prescription
drug to help with weight loss how likely are you to mention [DRUG] to him/her?
Not at all likely
Extremely likely
1
2
3
4
5
6
[SLIDERS]
Q22. Would this website mislead people about the effectiveness of [DRUG]?
No, definitely not
1
2
3
4
5
6
Q22b. Would this website mislead people about the risks of [DRUG]?
No, definitely not
1
2
3
4
5

Yes, definitely

Yes, definitely
6

[----------------------------------------New screen----------------------------------------]
[SLIDERS; RANDOMIZE ITEM ORDER Q23 – Q25]
[DISPLAY]
Please tell us how you feel about [DRUG].
Click and drag the square to a point on the scale that best reflects your opinion of [DRUG].
To me, [DRUG] is…
Q23.
A bad option

Q24.

Q25.

A good option
1

2

3

4

5

6

1

2

3

4

5

6

1

2

3

4

5

6

Harmful

Helpful

Useless

Useful

[----------------------------------------New screen----------------------------------------]
[SLIDERS]
[DISPLAY]

11

Last edited: June 30, 2017

Click and drag the square to a point on the scale that best reflects your opinion.
[RANDOMIZE ORDER OF ITEMS Q26 – Q27]
Q26. How likely is it that [DRUG] would help {you / your patients} lose weight if {you / they} took it?
Not at all likely
Extremely likely
1
2
3
4
5
6
Q27. How serious are [DRUG]’s side effects?
Not at all serious
1

2

Extremely
serious

3

4

5

6

[----------------------------------------New screen----------------------------------------]
[Consumer image]
[PROGRAMMER: Display website correspondent to the participant’s experimental
condition:
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 1 ‘Control’, DISPLAY IMAGE:
CID_S2_Cons_1.pdf
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 2 ‘Implicit’, DISPLAY IMAGE:
CID_S2_Cons_2.pdf
IF COHORT = 1 ‘Consumer’ AND XCONDITION = 3 ‘Explicit’, DISPLAY IMAGE:
CID_S2_Cons_3.pdf
]
[Provider image]
[PROGRAMMER: Display website correspondent to the participant’s experimental
condition:
IF COHORT = 2 ‘PCP’ AND XCONDITION = 1 ‘Control’, DISPLAY IMAGE:
CID_S2_PCP_1.pdf
IF COHORT = 2 ‘PCP’ AND XCONDITION = 2 ‘Implicit’, DISPLAY IMAGE:
CID_S2_PCP_2.pdf
IF COHORT = 2 ‘PCP’ AND XCONDITION = 3 ‘Explicit’, DISPLAY IMAGE:
CID_S2_PCP_3.pdf
]
[HOT SPOT COLLECTOR: CATEGORY SELECTION W/PREDEFINED AREAS & VERBATIM]
[DISPLAY]
Now we are going to show you the same website you saw at the start of the survey.
Click on any part of the website you think is inaccurate. If you do not think there is anything that is
inaccurate, select “None” above the image.
[PROGAMMER: For each category clicked within the image, participant will be asked….]
What makes this inaccurate?

12

Last edited: June 30, 2017

[----------------------------------------New screen----------------------------------------]
[MULTIPLE PUNCH]
Q29. If you saw a website or ad for a prescription drug that you thought was misleading or dishonest,
what would you do? Select all that apply.
Q29_1. I would not do anything.
Q29_2. I would contact the drug company.
Q29_3. I would contact the U.S. Food and Drug Administration (a federal government agency).
Q29_4. I would {tell my doctor or pharmacist / discuss it with my colleagues}.
Q29_5. I would talk to my family or friends.
Q29_6. I would post about it on social media.
Q29_8. I would discourage others from using the drug.
Q29_7. Other
[TEXTBOX] Q29_7_Open.__________________
[PROGRAMMER: IF Q29_8 = 1 ‘Selected’, ENABLE TEXTBOX FOR Q29_7_Open]
[----------------------------------------Next screen----------------------------------------]
[SLIDER]
Click and drag the square to a point on the scale that best reflects your opinion.
Q30. If there was a way to report misleading prescription drug websites or ads to the Food and Drug
Administration (FDA) by sending an e-mail or calling a toll-free phone number, how likely would you
be to report misleading material?
Not at all likely

Extremely likely
1

2

3

4

5

6

[SLIDER]
Q31. Thinking about the website that you saw, do you think it should be reported to the FDA as a
potentially misleading website?
No, definitely not

Yes, definitely
1

2

3

4

5

6

[----------------------------------------New screen----------------------------------------]
[DISPLAY]
The FDA’s "Bad Ad" program is an outreach effort to educate healthcare providers about the role they
can play in helping the FDA make sure that prescription drug ads and promotion are truthful and not
misleading. The program is designed to help healthcare providers recognize misleading prescription drug
promotion and provide them with an easy way to report misleading information to the FDA (via phone,
877-RX-DDMAC, or email, BadAd@fda.gov).
[SINGLE PUNCH]

13

Last edited: June 30, 2017

Q32.
1
2
998

Were you aware of this program?
Yes
No
Don’t know/Not sure

Q33.
1
2
998

[SINGLE PUNCH]
Do you think the Bad Ad program should be expanded to consumers?
Yes
No
Don’t know/Not sure

[----------------------------------------New screen----------------------------------------]
[PROGRAMMER: IF COHORT = 1 ‘CONSUMER’, SKIP Q34b, GO TO Q35]
[NUMERICAL FIELD; SET RANGE 0 – 10]
Q34. Rate your current knowledge about prescription weight loss drugs on a scale of 0 to 10, where 0
means knowing nothing and 10 means knowing everything you could possibly know about the
topic. _____
Q34b. Approximately what proportion of your current patients do you treat for obesity?
1 None or very few
2 A small proportion
3 About one-half
4 A large proportion
5 Everyone or almost everyone
[----------------------------------------New screen----------------------------------------]
[DISPLAY]
We are now done asking you about the website that you looked at today.
We would like to ask you about your personal views on {prescription drug websites / physiciantargeted prescription drug websites} in general. These are statements other people have made about
prescription drug websites.
Click and drag the square to a point on the scale that best reflects how much you agree or disagree with
each statement.
[SLIDERS; RANDOMIZE ORDER OF ITEMS Q35 – Q37e]
Q35. Prescription drug websites are a reliable source of information about the quality and performance of
medications.
Strongly disagree
Strongly agree
1
2
3
4
5
6
Q36. I feel I’ve been accurately informed after seeing most prescription drug websites.
Strongly disagree
Strongly agree
1
2
3
4
5
6
Q37. In general, prescription drug websites present a true picture of the drug being advertised.

14

Last edited: June 30, 2017

Strongly disagree

Strongly agree
1

2

3

4

5

6

Q37a. We can depend on getting the truth in most prescription drug websites.
Strongly disagree
1
2
3
4
5
6
Q37b. Prescription drug website’s aim is to inform {consumers / providers}.
Strongly disagree
1
2
3
4
5
6
Q37c. Prescription drug websites are informative.
Strongly disagree
1
2
3

Strongly agree

Strongly agree

Strongly agree
4

5

6

Q37d. Most prescription drug websites provide {consumers / providers} with essential information.
Strongly disagree
Strongly agree
1
2
3
4
5
6
Q37e. It bothers me when prescription drug websites make a drug seem better than it really is.
Strongly disagree
Strongly agree
1
2
3
4
5
6
[----------------------------------------New screen----------------------------------------]
Q37f. FDA must approve prescription drug websites before they appear online.
1 True
2 False
3 Don’t know
[----------------------------------------New screen----------------------------------------]
[PROGRAMMER: IF COHORT = 1 ‘PCP’, SKIP Q37g, GO TO ‘Q38_P’]
Q37g. In what situations, would you consider taking prescription drugs?
1
2
3
4

I would never take them
I would take them only for serious health conditions
I would take them for moderate and serious health conditions
I would take them for most health conditions, including minor problems

[PROGRAMMER: IF COHORT = 1 ‘Consumer’, SKIP Q38_P – Q40_P, GO TO ‘CONSUMER
DEBRIEF SCREEN’]
[----------------------------------------New screen----------------------------------------]
[ASK Q38_P – Q40_P IF COHORT = 2 ‘PCP’]
[NUMERICAL FIELD]
Q38_P. Since completing your residency, how many years have you been a healthcare provider?
_____ years
[SINGLE PUNCH]

15

Last edited: June 30, 2017

Q39_P. Have you received any formal training regarding pharmaceutical marketing (e.g., lectures,
presentations, classes, or computerized training)?
1 Yes
2 No
3 Don’t remember
[SINGLE PUNCH]
Q40_P. Have you received any informal training regarding pharmaceutical marketing (e.g., instructions
from a mentor regarding how to address direct-to-consumer advertising questions from a
patient)?
1 Yes
2 No
3 Don’t remember
[PROGRAMMER: IF COHORT = 2 ‘PCP’, GO TO ‘PROVIDER DEBRIEF SCREEN’]
[----------------------------------------New screen----------------------------------------]
[CONSUMER DEBRIEF SCREEN]
[DISPLAY IF COHORT = 1 ‘Consumer’]
You have been very helpful. Thank you very much for taking part in this survey!
The purpose of this study is see whether consumers can identify false or misleading prescription drug
information and how likely consumers are to report such information to regulatory authorities, such as the
FDA. [DRUG] is a fake drug and is not a product currently for sale. Please see your healthcare
professional for questions about your health and your medical conditions.
[PROVIDER DEBRIEF SCREEN]
[DISPLAY IF COHORT = 2 ‘PCP’]
You have been very helpful. Thank you very much for taking part in this survey!
The purpose of this study is to to see whether healthcare providers can identify false or misleading
prescription drug information and how likely providers are to report such information to regulatory
authorities. [DRUG] is a fictitious drug and is not a product currently for sale.

16